Endometrial Clear Cell Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Endometrial Clear Cell Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer [Phase 2]
A Phase 2 trial of metformin hydrochloride and doxycycline in localized breast or uterine cancers was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer [NA]
Update on a clinical trial evaluating PET/CT and lymph node mapping to detect lymph node metastasis in high-risk endometrial cancer patients…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer [Phase 3]
Phase 3 trial evaluating adding pembrolizumab to paclitaxel and carboplatin for stage III-IV or recurrent endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol [Phase 3]
Phase 3 randomized trial in endometrial/uterine cancers compares cisplatin plus radiation followed by carboplatin/paclitaxel versus a carbop…
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer [Phase 2, Phase 3]
Phase 2/3 trial evaluating paclitaxel and carboplatin with or without metformin in advanced or recurrent endometrial cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer [Phase 2]
Phase 2 trial evaluating cabozantinib S-Malate in recurrent or metastatic endometrial cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating dasatinib in recurrent or persistent ovarian, fallopian tube, endometrial, or peritoneal cancers; study terminated …
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer [Phase 1]
A Phase 1 trial evaluating the combination of dasatinib, paclitaxel, and carboplatin in patients with Stage III-IV or recurrent endometrial …
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating three regimens for endometrial cancer: paclitaxel-carboplatin-bevacizumab, paclitaxel-carboplatin-temsirolimus, and…
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine in patients with recurrent or persistent endometrial cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer [Phase 2]
Phase 2 clinical trial of trebananib for persistent or recurrent endometrial cancer has completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
A Phase 2 clinical trial of brivanib alaninate in patients with recurrent or persistent endometrial cancer has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer [Phase 2]
Phase 2 trial evaluating MK2206, an Akt inhibitor, in recurrent or advanced endometrial cancer; study completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating cediranib maleate for recurrent or persistent endometrial cancer has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer [Phase 1]
A Phase 1 trial update on combining chemotherapy with radiation therapy for patients with stage III or IV endometrial cancer, including endo…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer [Phase 1]
Phase 1 trial evaluating the safety of combining chemotherapy with radiation therapy for stage III or stage IV endometrial cancer has comple…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer [Phase 2]
This Phase II clinical trial update evaluates a multimodal therapy consisting of intensity-modulated radiation therapy with cisplatin and be…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial of selumetinib in recurrent or persistent endometrial cancer has completed with results posted in 2014.